United States HHS should create a program to provide a demand floor for vaccines (Lyme, dengue, chikungunya, HPAI, EEEV) where the presence of an available vaccine presents a major public health value in excess of what companies can recoup in direct sales.
add a skeleton here at some point
over 1 year ago